Healio Minute Podcast, Hematology Oncology Edition: Top Headlines - Week of November 7, 2022
Click Here to Manage Email Alerts
In this edition, FDA approves Tecvayli for multiple myeloma, radiation and hormone therapy slows progression of prostate cancer, and more.
Read the full coverage here:
FDA approves Tecvayli for advanced multiple myeloma
Adding radiation to hormone therapy slows progression of oligometastatic prostate cancer
Use of cannabis during cancer treatment may have ‘under-appreciated’ financial impact
Older cancer survivors at higher risk for bone fracture
Machine-learning approach using step counts predicts hospitalization during radiotherapy
References:
Chino F, et al. Abstract 24. Presented at: ASCO Quality Care Symposium; Sept. 30-Oct. 1, 2022; Chicago.
Friesner I, et al. Abstract 132. Presented at: American Society for Radiation Oncology Annual Meeting; Oct. 23-26, 2022; New Orleans.
Rees-Punia E, et al. JAMA Oncol. 2022;doi:10.1001/jamaoncol.2022.5153.
Tang C, et al. Abstract LBA 05. Presented at: American Society for Radiation Oncology Annual Meeting; Oct. 23-26, 2022; San Antonio.
Collapse
Click Here to Manage Email Alerts
